Delivery Order SPE2DB20D3505-SPE2DB26FYCFB
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,531.80 by the Defense Logistics Agency on September 10, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,606.92 for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL on April 29, 2025, with an ultimate completion date of April 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and is funded by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 15, 2025, valued at $100,235.63 for HUMIRA Pen 40MG/4ML (2 pens) under a firm fixed-price contract. The award, issued without a set-aside designation, is expected to be completed by October 10, 2025, with performance taking place at the awardee's Conshohocken facility. This delivery order is a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical product, with a ceiling value of $3,210.96. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by July 29, 2025. The place of performance is listed as AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $9,916.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to a location in Conshohocken, Pennsylvania. The contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and does...
- AmerisourceBergen Drug Corp received a competitive delivery order award from the Defense Logistics Agency (DLA) valued at $8,291.76 for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for immunological conditions. The contract is unclassified as a set-aside and carries a firm fixed-price structure with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters, where...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,967.32 by the Defense Logistics Agency's Medical Supply Chain on June 25, 2025, for the supply of HUMIRA Pen 40mg/4ml in a quantity of two units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of HUMIRA(CF) Pen 40 mg/0.4 mls, a prescription immunosuppressant medication. The contract carries a ceiling value of $5,281.33 and features firm fixed-price pricing with an ultimate completion date of September 18, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,063.60 by the Defense Logistics Agency on October 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 16, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...